Dangsim K-7
- Manufacturer
- Korea Genetic Pharm Co., Ltd
- Effective date
- 2012-02-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:06
Label at a glance#
ProductDangsim K-7
Active ingredientMOMORDICA CHARANTIA FRUIT
Label structure8 sections
Label contents#
Full prescribing information#
active ingredient: momordica charantia powder
INACTIVE INGREDIENT SECTION
banaba leaf powder, indigestible maltodextrin, red ginseng powder, soybean powder
OTC - PURPOSE SECTION
hypoglycemic agent / helps insulin secretion / strengthen level of immunity
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
take 2 pouch every day (taking before breakfast and dinner)
WARNINGS SECTION
if a fever occurs or you feel dizzy after taking this drugs, immediately stop taking
DOSAGE & ADMINISTRATION SECTION
do not take if you have heart disease
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42707-1001-2 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d373-f6ea-e053-dbdaa90aa703 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42707-1001-1 | Dangsim K-7 | 5 g in 1 POUCH | GRANULE | 5 | 1 | |
| 42707-1001-2 | Dangsim K-7 | 60 in 1 BOX | GRANULE | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 42707-1001 | DANGSIM K-7 (MOMORDICA CHARANTIA FRUIT) GRANULE [KOREA GENETIC PHARM CO., LTD ] | 1 | Legacy NDC, 2 package rows | 20120308_4bb77558-0348-483e-86d8-11e98b7db123.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MOMORDICA CHARANTIA FRUIT | ACTIVE INGREDIENT | UA63Y8U89U | 1 | |
| MOMORDICA CHARANTIA FRUIT | ACTIVE MOIETY | UA63Y8U89U | 1 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | 1 | |
| PANAX GINSENG FRUIT | INACTIVE INGREDIENT | E35T4MOI3E | 1 | |
| SOYBEAN | INACTIVE INGREDIENT | L7HT8F1ZOD | 1 |
Products#
Every source-derived product name is available through these pages.
- Dangsim K-7
- MOMORDICA CHARANTIA FRUIT
- MALTODEXTRIN
- PANAX GINSENG FRUIT
- SOYBEAN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 42707-1001 | 42707-1001-1, 42707-1001-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MOMORDICA CHARANTIA FRUIT | UA63Y8U89U | ACTIB |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| PANAX GINSENG FRUIT | E35T4MOI3E | IACT |
| SOYBEAN | L7HT8F1ZOD | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | NA | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | 320 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | LOZENGE / ORAL | 175 mg | ||
| SOYBEAN | SOYBEAN | L7HT8F1ZOD | CAPSULE / ORAL | NA | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | GRANULE, FOR SUSPENSION / ORAL | 952 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | PASTE / ORAL | 1050 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | SUSPENSION / ORAL | 6040 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, COATED / ORAL | 5.6 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | SOLUTION / ORAL | 1451 mg | ||
| SOYBEAN | SOYBEAN | L7HT8F1ZOD | EMULSION / TOPICAL | 3 %w/w | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | FILM, SOLUBLE / ORAL | 19 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | CAPSULE / ORAL | 200 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | POWDER, FOR SUSPENSION / ORAL | 8000 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EFFERVESCENT / ORAL | 14404 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EXTENDED RELEASE / ORAL | 3239 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| daca2668-d76f-4e0f-b7da-3224ffffdbae | 4bb77558-0348-483e-86d8-11e98b7db123 | 2012-02-15 | Warnings | daca2668-d76f-4e0f-b7da-3224ffffdbae 4bb77558-0348-483e-86d8-11e98b7db123 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
